$25 – $30

Medical Cannabis an emerging industry - Seedlings 2017

Event Information

Share this event

Date and Time

Location

Location

Tank Stream Labs

Level 4

17-19 Bridge Street

Sydney, NSW 2000

Australia

View Map

Refund Policy

Refund Policy

Refunds up to 7 days before event

Friends Who Are Going
Event description

Description

Gain an in-depth understanding of the emerging political/economic trends and investment opportunities within the medical cannabis industry

Ticket Sales Are Limited to 100!


Overview of event:

In collaboration with Spark Festival, medical cannabis accelerator, 'BuddingTech' are hosting, 'Seedlings 2017'. Last year, Seedlings was launched and was noted as a resounding success highlighting the key challenges and opportunities that exist in the medical cannabis industry.

Set to be worth more than $50 billion within the next 10 years, Medical cannabis is unquestionably an emerging growth industry, but are you up to speed on the latest industry knowledge? Seedlings has been designed to raise awareness of the challenges and opportunities presented by medical cannabis to develop a responsible, innovative, and politically-engaged legal cannabis industry in Australia.

Spend the evening learning about innovation and the latest advancements in the medical cannabis industry. BuddingTech invites you to join us for an insightful evening where you can expect to come away with an understanding of current investment opportunities and the emerging start-ups that are shaping this rapidly expanding sector.

Research has already shown that cannabis can be beneficial in the treatment of chronic pain, epilepsy, multiple sclerosis, Parkinson’s disease, anxiety, depression and many more conditions. You will hear from a patient that, despite such findings, patient access is bound by red tape, and what can be done to increase access.

The event will present a series of speakers who will provide insight into the cannabis industry from a technology, medical, industry, and regulatory perspective. There will also be a panel of industry experts and guests from the medical cannabis community.


Times and speakers:

6.00pm: Drinks + Networking

6:30pm: Presentation from Ben Oakley - patient advocate

6:45pm: Presentation from Blaise Bratter - BuddingTech / Medical Cannabis Council

7.00pm: Presentation from Dr Ross Walker - MGC Pharma (Keynote)

7:15pm: Break for networking

7:30pm: Panel discussion

8:00pm: Panel Q&A

8:30pm: Panel concludes and networking begins

9:00pm: Event concludes

*Please note that drinks and light refreshments will be provided.

Speakers:

Ben Oakley - The patient's perspective

Ben is a medical cannabis campaigner and activist. He has an incredible story about using cannabis oil to treat a rare condition that he suffers from known as, ‘stiff person syndrome’. Ben will share his harrowing experiences with conventional treatment options and he will outline exactly why he is a devoted advocate for medical cannabis.

Blaise Bratter, General Manager - Medical Cannabis Council / BuddingTech

The Medical Cannabis Council Ltd. launched earlier this year and is proudly presenting Australia's first national not-for-profit body representing the medical cannabis industry.

The Mission of the Medical Cannabis Council is to create a unifying voice for the medical cannabis industry in Australia, facilitating a framework of best practice and supporting the positioning of Australia as a world leader in research and production of safe, scientifically backed medical cannabis products.


Dr Ross Walker - MGC Pharma

Dr Ross Walker is an eminent practicing cardiologist with a passion for people and health. Considered one of the world’s best keynote speakers and life coaches, he is the author of seven books (all of which have been best-sellers). Dr Walker is also a regular presenter on the Nine Network’s Today Show and A Current Affair and has most recently appeared as the medical expert on Excess Baggage. He also presents on radio stations 2UE, 6PR, 4BC and 3AW.

MGC Pharmaceuticals Limited (MGC), is a Perth based bio-pharmaceutical publically traded company with a focus on phytocannabinoid medications. The company has a research facility in Ljubljana, Slovenia, and is actively involved in research into phytocannabinoids and their potential for medical applications in both countries.

Capitalizing on years of experience in the innovative Israeli Medical Cannabis market, combined with exclusive strains of high CBD genetics and first to market advantages globally, MGC is creating a seamless, highly supervised supply chain, from planting to extraction, creating the highest quality resins, oils and proprietary delivery devices available in the market.

Panel:

We are currently putting together a list of notable medical cannabis industry leaders for our panel - we will be announcing this shortly. Current Panel speakers include:

Prof Michael Katz - Director at Ripple Capital

Michael Katz has worked in the academic sector for both the University of Sydney and UNSW, where his focus has been on developing and implementing social investment projects and internship programs within the business faculties, as well as managing action research projects. This includes initiating and managing the Medical Cannabis White Paper developed in collaboration with MGC Pharmaceuticals and Budding Tech.

Catherine Harvey - Chief Operations Officer of MMJ Phytotech

Ms. Catherine Harvey is a highly experienced pharmaceutical industry executive, with an extensive corporate background, having worked for multiple pharmaceutical organisations both domestically and overseas. She held executive leadership positions including Director of Business Development and Corporate Affairs at Mundipharma Pty Limited and Business Development Manager at Norwegian Pharmaceutical company, Nycomed.

Justin Sinclair - Research Fellow at NICM

Justin is a Research Fellow at NICM, an international leader in integrative medicine research based at Western Sydney University where he is also the co-ordinator of the Australian Medicinal Cannabis Research & Education Collaboration. For the last 2 years he has also served on United in Compassion’s Scientific Advisory Board, Australia’s leading medicinal cannabis patient advocacy group, in a pro bono capacity. His scientific background is in pharmacognosy (i.e. drugs that come from plants), but his research interests extend into botany, ethnopharmacology, analytical Phytochemistry, horticulture, and pathophysiology. He is currently a co-investigator on several clinical research projects in development around medicinal Cannabis and spends much of his time lecturing to medical practitioners, nurses, politicians and other allied health professionals about the therapeutic applications of the Cannabis genus. Justin has many years of industry experience in areas such as quality assurance, new product development and regulatory affairs involving herbal medicines and is a strong supporter of full spectrum plant extracts and understanding the deeper workings of the entourage effect.

DR. Teresa Nicoletti (Partner) - Mills Oakley

Dr Teresa Nicoletti leads Mills Oakley’s national IP, Health and Life Sciences team. Teresa is both a lawyer and scientist with more than 20 years’ experience in the pharmaceutical, biotechnology and medical device industries in Australia and New Zealand. She has also worked across a number of other product-related industries, including foods, cosmetics, veterinary pharmaceuticals, agrochemicals and industrial chemicals. More recently, a lot of her work has centered around the developing medicinal cannabis framework at both the Commonwealth and State/Territory levels.

Share with friends

Date and Time

Location

Tank Stream Labs

Level 4

17-19 Bridge Street

Sydney, NSW 2000

Australia

View Map

Refund Policy

Refunds up to 7 days before event

Save This Event

Event Saved